Miami, FL, United States of America

Antonio Pinna

This inventor holds 1 USPTO granted patent. Top assignee: University of Miami. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Pinna. Retrieved from https://idiyas.com/inventor/antonio-pinna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Pinna: Innovator in Hepatitis C Treatment

Introduction

Antonio Pinna is a notable inventor based in Miami, FL, who has made significant contributions to the field of medical research. His innovative approach to treating hepatitis C has the potential to improve the lives of many patients suffering from this severe viral infection.

Latest Patents

Antonio Pinna holds a patent for a novel method titled "Treatment of hepatitis C by administration of anti-IL-2 receptor monoclonal antibody." This inventive method utilizes anti-interleukin 2 receptor monoclonal antibodies to treat patients with severe viral hepatitis C. The method is particularly beneficial for treating recurrent hepatitis C following liver transplantation, as it helps reduce complications in recipients of liver allografts. He has 1 patent to his name.

Career Highlights

Antonio Pinna is affiliated with the University of Miami, where he conducts his research and develops innovative treatments. His work has garnered attention for its potential impact on the medical community and patient care.

Collaborations

Some of his notable coworkers include Camillo D Ricordi and Andreas G Tzakis, who have collaborated with him on various research projects.

Conclusion

Antonio Pinna's contributions to the treatment of hepatitis C exemplify the importance of innovation in medicine. His work not only advances scientific knowledge but also offers hope to patients facing challenging health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…